Previous 10 | Next 10 |
home / stock / gdrx / gdrx articles
LOS ANGELES, May 21, 2024 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class a...
NEW YORK, May 20, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of GoodRx...
NEW YORK, May 16, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investo...
GoodRx Holdings Inc. (GDRX) shares surged nearly 10% Wednesday afternoon following the announcement of a new direct contracting agreement with Krog...
NEW YORK, May 15, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of GoodRx...
U.S. stocks were higher, with the Dow Jones gaining around 150 points on Wednesday. Shares of Nextracker Inc. (NASDAQ:NXT) rose sharply during Wedn...
NEW YORK, May 14, 2024 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in GoodRx Holdings, Inc. ("GoodRx" or the "C...
SAN DIEGO, May 13, 2024 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and ...
NEW YORK, May 12, 2024 (GLOBE NEWSWIRE) -- NEW YORK, May 12, 2024 (GLOBENEWSWIRE) Pomerantz LLP announces that a class action lawsuit has been f...
News, Short Squeeze, Breakout and More Instantly...
Boehringer Ingelheim and GoodRx announce exclusive patient affordability initiative for Adalimumab-adbm injection, Boehringer's biosimilar to Humira® PR Newswire First biosimilar with an exclusive low cash price on the GoodRx platform RIDGEFIELD, Conn. and S...
GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading prescription savings platform in the U.S., today announced it will release its second quarter 2024 financial results before U.S. markets open on Thursday, August 8, 2024. GoodRx management ...
Former Genentech CEO brings over 35 years of pharmaceutical and healthcare expertise to GoodRx GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," “GoodRx” or the “Company”), the leading prescription savings platform in the U.S., today announced the ...